AKTIS ONCOLOGY INC
AKTS·01021M104·US·Common Stock-Activist
AKTS (AKTIS ONCOLOGY INC) is held by 49 institutional investors as of Q1 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($41.5M), BlackRock, Inc. ($37.8M), RTW INVESTMENTS, LP ($28.5M). Net institutional sentiment: Bullish.
49
Holders
(2 Elite)
$285M
Total Value
100% (49)
Consensus
49 buying - 0 selling
13F: Insider & Congress:
Who's Trading
InsiderCACzibere AkosSell $401KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $429KJul 8, 2026
InsiderCACzibere AkosSell $862KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $838KJul 8, 2026
InsiderRSRon-Bigger ShulamitSell $121KJul 8, 2026
InsiderCACzibere AkosSell $125KJul 8, 2026
ActivistBOBlue Owl Capital Holdings LP5.9%May 14, 2026
ActivistMBMPM BIOVENTURES 2018, L.P.7.4%Jan 20, 2026
ActivistECEcoR1 Capital, LLC9.1%Jan 20, 2026
ActivistELEli Lilly and Company11.9%Jan 15, 2026
Top Holders
Showing 1-20 of 49
1 / 3
Continue exploring
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer